日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.

ENHANCE-1 试验中转移性三阴性乳腺癌患者对艾立布林加帕博利珠单抗治疗反应的空间生物标志物

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00791-2
Foong Yee Hoon, Wang Qi, Kearney Matthew, Le Hortense, Guo Hua, Chen Diane, Politis Michelle Garlin, Connelly Courtney F, Kalinsky Kevin, Vanguri Rami S, Connolly Eileen P
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

PD-L1和PD-L2基因改变定义了经典型霍奇金淋巴瘤并预测了预后

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2016.66.4482
Roemer, Margaretha G M; Advani, Ranjana H; Ligon, Azra H; Natkunam, Yasodha; Redd, Robert A; Homer, Heather; Connelly, Courtney F; Sun, Heather H; Daadi, Sarah E; Freeman, Gordon J; Armand, Philippe; Chapuy, Bjoern; de Jong, Daphne; Hoppe, Richard T; Neuberg, Donna S; Rodig, Scott J; Shipp, Margaret A
PD-L1
淋巴瘤
发表日期：2016
文献求助 收藏

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

β2M/MHC I类分子表达降低的经典型霍奇金淋巴瘤与较差的预后相关，且与9p24.1状态无关。

期刊:Cancer Immunology Research
影响因子:8.2
doi:10.1158/2326-6066.CIR-16-0201
Roemer, Margaretha G M; Advani, Ranjana H; Redd, Robert A; Pinkus, Geraldine S; Natkunam, Yasodha; Ligon, Azra H; Connelly, Courtney F; Pak, Christine J; Carey, Christopher D; Daadi, Sarah E; Chapuy, Bjoern; de Jong, Daphne; Hoppe, Richard T; Neuberg, Donna S; Shipp, Margaret A; Rodig, Scott J
淋巴瘤
发表日期：2016
文献求助 收藏